Related references
Note: Only part of the references are listed.Dopamine and Levodopa Prodrugs for the Treatment of Parkinson's Disease
Fatma Haddad et al.
MOLECULES (2018)
Crossing the blood-brain barrier with nanoparticles
Yiqun Zhou et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Progress in brain targeting drug delivery system by nasal route
Abdur Rauf Khan et al.
JOURNAL OF CONTROLLED RELEASE (2017)
ICAM-1 targeting, intracellular trafficking, and functional activity of polymer nanocarriers coated with a fibrinogen-derived peptide for lysosomal enzyme replacement
Carmen Garnacho et al.
JOURNAL OF DRUG TARGETING (2017)
Intravenous infusion of iduronidase-IgG and its impact on the central nervous system in children with Hurler syndrome
Roberto Giugliani et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years
Hanadi Sinokrot et al.
MOLECULES (2017)
Carbon dots: promising biomaterials for bone-specific imaging and drug delivery
Zhili Peng et al.
NANOSCALE (2017)
Functional single-walled carbon nanotubes 'CAR' for targeting dopamine delivery into the brain of parkinsonian mice
Qing Guo et al.
NANOSCALE (2017)
Brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole
Joshua S. Frankel et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2017)
Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives
Melani Solomon et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Delivery of Biologics Across the Blood-Brain Barrier with Molecular Trojan Horse Technology
William M. Pardridge
BIODRUGS (2017)
Recent Approaches to Platinum(IV) Prodrugs: A Variety of Strategies for Enhanced Delivery and Efficacy
Anas Najjar et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment
Chenchen Bi et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets
Tengfei Li et al.
JOURNAL OF CONTROLLED RELEASE (2016)
A review of intranasal formulations for the treatment of seizure emergencies
Mamta Kapoor et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Transferrin conjugated nontoxic carbon dots for doxorubicin delivery to target pediatric brain tumor cells
Shanghao Li et al.
NANOSCALE (2016)
Progress and perspectives on targeting nanoparticles for brain drug delivery
Huile Gao
ACTA PHARMACEUTICA SINICA B (2016)
Brain targeted nanoparticulate drug delivery system of rasagiline via intranasal route
Deepti Mittal et al.
DRUG DELIVERY (2016)
Nanoparticle-Based Combination Therapy for Cancer Treatment
Ji Young Yhee et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core
Andrew J. Clark et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Release behaviour and toxicity evaluation of levodopa from carboxylated single-walled carbon nanotubes
Julia M. Tan et al.
BEILSTEIN JOURNAL OF NANOTECHNOLOGY (2015)
Detection of Mycobacterium tuberculosis based on H37Rv binding peptides using surface functionalized magnetic microspheres coupled with quantum dots - a nano detection method for Mycobacterium tuberculosis
Hua Yang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
Transporter-Based Delivery of Anticancer Drugs to the Brain: Improving Brain Penetration by Minimizing Drug Efflux at the Blood-Brain Barrier
Ngoc H. On et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Comparison of Five Peptide Vectors for Improved Brain Delivery of the Lysosomal Enzyme Arylsulfatase A
Annika Boeckenhoff et al.
JOURNAL OF NEUROSCIENCE (2014)
Alpha synuclein is transported into and out of the brain by the blood-brain barrier
Yu-Ting Sui et al.
PEPTIDES (2014)
Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB
Shih-hsin Kan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Blood-Brain Barrier Permeable Gold Nanoparticles: An Efficient Delivery Platform for Enhanced Malignant Glioma Therapy and Imaging
Yu Cheng et al.
SMALL (2014)
Nanoparticle approaches against bacterial infections
Weiwei Gao et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2014)
Carbon nanotubes in neuroregeneration and repair
Alessandra Fabbro et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Carbon nanotubes as optical biomedical sensors
Sebastian Kruss et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Regional distribution of SGLT activity in rat brain in vivo
Amy S. Yu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2013)
B6 Peptide-Modified PEG-PLA Nanoparticles for Enhanced Brain Delivery of Neuroprotective Peptide
Zhongyang Liu et al.
BIOCONJUGATE CHEMISTRY (2013)
Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier
Ja-Young Kim et al.
BIOMATERIALS (2013)
Pharmacokinetics and brain uptake in the rhesus monkey of a fusion protein of arylsulfatase a and a monoclonal antibody against the human insulin receptor
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2013)
Blood-brain barrier structure and function and the challenges for CNS drug delivery
N. Joan Abbott
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
Immune Therapy of Multiple Sclerosis - Future Strategies
Sven G. Meuth et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Toward Eradicating HIV Reservoirs in the Brain: Inhibiting P-Glycoprotein at the Blood-Brain Barrier with Prodrug Abacavir Dimers
Hilda A. Namanja et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Zidovudine and Ursodeoxycholic Acid Conjugation: Design of a New Prodrug Potentially Able To Bypass the Active Efflux Transport Systems of the Central Nervous System
Alessandro Dalpiaz et al.
MOLECULAR PHARMACEUTICS (2012)
Enhanced delivery of α-glucosidase for Pompe disease by ICAM-1-targeted nanocarriers: comparative performance of a strategy for three distinct lysosomal storage disorders
Janet Hsu et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Tools for eradicating HIV in the brain: prodrug dimeric inhibitors of P-gp
Jean Chmielewski et al.
THERAPEUTIC DELIVERY (2012)
Safety evaluation of biological drugs: What are toxicology studies in primates telling us?
Paul Baldrick
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2011)
Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery
Patrick T. Ronaldson et al.
THERAPEUTIC DELIVERY (2011)
The Pharmacokinetics of Cell-Penetrating Peptides
Dikran Sarko et al.
MOLECULAR PHARMACEUTICS (2010)
Silver Nanoparticle Induced Blood-Brain Barrier Inflammation and Increased Permeability in Primary Rat Brain Microvessel Endothelial Cells
William J. Trickler et al.
TOXICOLOGICAL SCIENCES (2010)
Addressing Central Nervous System (CNS) Penetration in Drug Discovery: Basics and Implications of the Evolving New Concept
Andreas Reichel
CHEMISTRY & BIODIVERSITY (2009)
Tight junction modulator and drug delivery
Koji Matsuhisa et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
AGT-181: Expression in CHO cells and pharmacokinetics, safety, and plasma iduronidase enzyme activity in Rhesus monkeys
Ruben J. Boado et al.
JOURNAL OF BIOTECHNOLOGY (2009)
Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2
A. Regina et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Design, synthesis and biological evaluation of glutathione peptidomimetics as components of anti-Parkinson prodrugs
Swati S. More et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Large neutral amino acid transporter enables brain drug delivery via prodrugs
Mikko Gynther et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2
Michel Demeule et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Delivery of acid sphingomyelinase in normal and Niemann-Pick disease mice using intercellular adhesion molecule-1-targeted polymer nanocarriers
Carmen Garnacho et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Galactosylated dopamine enters into the brain, blocks the mesocorticolimbic system and modulates activity and scanning time in Naples high excitability rats
L. A. Ruocco et al.
NEUROSCIENCE (2008)
Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier
Ruben J. Boado et al.
BIOTECHNOLOGY AND BIOENGINEERING (2008)
Transvascular delivery of small interfering RNA to the central nervous system
Priti Kumar et al.
NATURE (2007)
Novel L-dopa and dopamine prodrugs containing a 2-phenyl-imidazopyridine moiety
Nunzio Denora et al.
PHARMACEUTICAL RESEARCH (2007)
Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis
K Benchenane et al.
CIRCULATION (2005)
Critical role of tight junctions in drug delivery across epithelial and endothelial cell layers
L Gonzalez-Mariscal et al.
JOURNAL OF MEMBRANE BIOLOGY (2005)
LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms
R Deane et al.
NEURON (2004)
Synthesis of glycosyl derivatives as dopamine prodrugs:: interaction with glucose carrier GLUT-1
C Fernández et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2003)
Expression of the neonatal Fc receptor (FcRn) at the blood-brain barrier
F Schlachetzki et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system
Y Zhang et al.
STROKE (2001)
Rapid transferrin efflux from brain to blood across the blood-brain barrier
Y Zhang et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of tbe neurotrophin
Y Zhang et al.
BRAIN RESEARCH (2001)
Inhibition of the increased permeability of blood-brain barrier in Escherichia coli-induced meningitis by carboxyfullerene
N Tsao et al.
FULLERENE SCIENCE AND TECHNOLOGY (2001)
Recombinant human adenovirus: Targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium
HB Xia et al.
JOURNAL OF VIROLOGY (2000)
Synthesis and biological studies of glycosyl dopamine derivatives as potential antiparkinsonian agents
C Fernández et al.
CARBOHYDRATE RESEARCH (2000)
New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy
C Rousselle et al.
MOLECULAR PHARMACOLOGY (2000)
Systemically administered D-glucose conjugates of 7-chlorokynurenic acid are centrally available and exert anticonvulsant activity in rodents
G Battaglia et al.
BRAIN RESEARCH (2000)
Share Paper
